Now live: Pro — the full 13F research suite for serious investorsSee pricing →
← Tracker

Institutional

Vitruvian Partners LLP

CIK 0001692590
$111.8M
Reported AUM
7
Positions
Q1 2026
Period
2026-05-11
Filed

The Brief · Vitruvian Partners LLP · Q1 2026

AI · grounded in 13F

Vitruvian Partners LLP reported no changes to its 13F holdings for 2026-03-31 relative to 2025-12-31.

Portfolio · Q1 2026

HNGE$48.2MMQ$28.0MCARG$16.1MXMTR$7.8MGLBE$6.5MMXCTVL

Top holdings

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1HNGEHINGE HEALTH INC$75.390.38%67.10%45.14%$48.2M43.09%HELD
2MQMARQETA$17.29-2.04%-20.21%-84.81%$28.0M25.00%HELD
3CARGCARGURUS INC$35.80-0.56%12.99%18.50%$16.1M14.40%HELD
4XMTRXOMETRY INC$84.57-0.41%173.29%16.84%$7.8M7.01%HELD
5GLBEGLOBAL-E$39.36-1.28%26.89%-49.51%$6.5M5.80%HELD
6MXCTMAXCYTE$1.04-0.48%-48.53%-93.16%$3.5M3.17%HELD
7RXSTRXSIGHT$5.88-3.29%-22.05%-60.47%$1.7M1.54%HELD

Source: SEC EDGAR · accession 0001420506-26-000881. 13F discloses long positions only — shorts, foreign equities, and options are excluded.